BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15172934)

  • 1. Hepatic resection of the intraductal papillary type of peripheral cholangiocarcinoma.
    Yeh CN; Jan YY; Yeh TS; Hwang TL; Chen MF
    Ann Surg Oncol; 2004 Jun; 11(6):606-11. PubMed ID: 15172934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age on surgical treatment of peripheral cholangiocarcinoma.
    Yeh CN; Jan YY; Chen MF
    Am J Surg; 2004 Apr; 187(4):559-63. PubMed ID: 15041513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatectomy for peripheral cholangiocarcinoma in elderly patients.
    Yeh CN; Jan YY; Chen MF
    Ann Surg Oncol; 2006 Dec; 13(12):1553-9. PubMed ID: 17009157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma.
    Jan YY; Jeng LB; Hwang TL; Wang CS; Chen MF; Chen TJ
    Hepatogastroenterology; 1996; 43(9):614-9. PubMed ID: 8799405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma.
    Suh KS; Roh HR; Koh YT; Lee KU; Park YH; Kim SW
    Hepatology; 2000 Jan; 31(1):12-7. PubMed ID: 10613721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical approach to bismuth Type I and II hilar cholangiocarcinomas: audit of 54 consecutive cases.
    Ikeyama T; Nagino M; Oda K; Ebata T; Nishio H; Nimura Y
    Ann Surg; 2007 Dec; 246(6):1052-7. PubMed ID: 18043110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gross pathological classification of peripheral cholangiocarcinoma determines the efficacy of hepatectomy.
    Yeh CN; Yeh TS; Chen TC; Jan YY; Chen MF
    J Gastroenterol; 2013 May; 48(5):647-59. PubMed ID: 23001251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma.
    Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Shimamura F; Shimizu Y; Miyazaki M
    J Hepatobiliary Pancreat Surg; 2003; 10(4):259-64. PubMed ID: 14598144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience.
    Konstadoulakis MM; Roayaie S; Gomatos IP; Labow D; Fiel MI; Miller CM; Schwartz ME
    Am J Surg; 2008 Aug; 196(2):160-9. PubMed ID: 18466862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
    Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Miyazaki M
    Br J Surg; 2002 Dec; 89(12):1525-31. PubMed ID: 12445060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?
    Miyazaki M; Kato A; Ito H; Kimura F; Shimizu H; Ohtsuka M; Yoshidome H; Yoshitomi H; Furukawa K; Nozawa S
    Surgery; 2007 May; 141(5):581-8. PubMed ID: 17462457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of MUC4 for mass-forming intrahepatic cholangiocarcinoma after hepatectomy.
    Yeh CN; Pang ST; Wu RC; Chen TW; Jan YY; Chen MF
    Oncol Rep; 2009 Jan; 21(1):49-56. PubMed ID: 19082442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
    Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
    Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
    Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
    Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.